Postprogression therapy and confounding for the estimated treatment effect on overall survival in phase III oncology trials

Objective Estimations of the treatment effect on overall survival (OS) may be influenced by post-progression therapies (PPTs). It is unclear how often OS analyses account for PPT effects. The purpose of this cross-sectional analysis was to determine the prevalence of OS analyses accounting for PPT e...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Pavlos Msaouel, Ramez Kouzy, Joseph Abi Jaoude, Ethan B Ludmir, Alexander D Sherry, Timothy A Lin, Esther J Beck, Avital M Miller, Adina H Passy, Gabrielle S Kupferman, Eugene J Koay, Clifton David Fuller, Charles R Thomas, Zachary R McCaw
Formato:	Artigo
Idioma:	Inglês
Publicado em:	BMJ Publishing Group 2024-07-01
coleção:	BMJ Oncology
Acesso em linha:	https://bmjoncology.bmj.com/content/3/1/e000322.full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!